Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer

NCT07174583 is registered in ClinicalTrials.gov with IDEAYA Biosciences as lead sponsor.

NCT NCT07174583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer
Lead sponsor
IDEAYA Biosciences
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 14, 2025
Completion date
July 31, 2029
Enrollment
262 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine carcinomas, small-cell lung cancer, solid tumor show to express dll3